US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phio Pharmaceuticals

1.86

-0.1200-6.06%

Volume:87.26K

Turnover:165.56K

Market Cap:8.89M

PE:-0.20

High:2.04

Open:1.95

Low:1.82

Close:1.98

Loading ...

Overview Company News Filings

Phio Pharmaceuticals Unveils $3.2 Million Registered Direct Offering; Shares Fall

MT Newswires Live

Phio Pharmaceuticals Corp trading resumes

Phio Pharmaceuticals Corp trading halted, volatility trading pause

Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge

Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why

Phio Pharma Shares Triple After Positive Trial Data for Cancer Treatment

Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762

Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell

MT Newswires Live

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BRIEF-Phio Pharmaceuticals Positive Safety Monitoring Committee Recommendation To Continue To Third Dose Cohort In Its Clinical Study Of Ph-762

Phio Pharmaceuticals: Positive Safety Monitoring Committee Recommendation to Continue to Third Dose Cohort in Its Clinical Study of Ph-762

THOMSON REUTERS

Phio Pharmaceuticals Corp: Intratumoral Injections Have Been Well Tolerated

THOMSON REUTERS

Phio Pharmaceuticals Corp: No Dose-Limiting Toxicities, or Serious Adverse Events in Participants Receiving Intratumoral Ph-762

THOMSON REUTERS

Phio Pharmaceuticals Safety Panel Approves Dose Escalation in Skin Cancer Trial

MT Newswires Live

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762

Phio Pharmaceuticals Announces Publication in Frontiers in Immunology

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PHIO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":1.86,"timestamp":1746024966145,"preClose":1.98,"halted":0,"volume":87262,"delay":0,"floatShares":4773366,"shares":4778154,"eps":-9.079757,"marketStatus":"Trading","change":-0.12,"latestTime":"04-30 10:56:41 EDT","open":1.95,"high":2.0352,"low":1.815,"amount":165560.3513718,"amplitude":0.111212,"askPrice":1.87,"askSize":100,"bidPrice":1.84,"bidSize":1327,"shortable":3,"etf":0,"ttmEps":-9.079757,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.98,"preHourTrading":{"tag":"盘前","latestPrice":2.05,"preClose":1.98,"latestTime":"08:55 EDT","volume":2750,"amount":5576.47915,"timestamp":1746017701166},"postHourTrading":{"tag":"盘后","latestPrice":1.99,"preClose":1.98,"latestTime":"19:35 EDT","volume":6048,"amount":12131.6787,"timestamp":1745969715761},"volumeRatio":0.756706,"impliedVol":2.2675,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","floatShares":4773366,"roa":"-61.14%","roe":"-114.83%","lyrEps":-9.079757,"volumeRatio":0.756706,"shares":4778154,"dividePrice":0,"high":2.0352,"amplitude":0.111212,"preClose":1.98,"low":1.815,"week52Low":0.9657,"pbRate":"1.88","week52High":9.79,"institutionHeld":0,"latestPrice":1.86,"committee":0.859846,"eps":-9.079757,"divideRate":0,"volume":87262,"delay":0,"ttmEps":-9.079757,"open":1.95,"prevYearClose":1.8,"prevWeekClose":2.04,"prevMonthClose":1.3,"prevQuarterClose":1.3,"fiveDayClose":2.04,"twentyDayClose":1.23,"sixtyDayClose":2.04},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHIO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503950363","title":"Phio Pharmaceuticals Unveils $3.2 Million Registered Direct Offering; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2503950363","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503950363?lang=en_us&edition=fundamental","pubTime":"2025-01-15 00:23","pubTimestamp":1736871799,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals  said Tuesday it signed agreements to buy and sell a total of about 1.1 million of its common shares at a purchase price of $3 apiece in a registered direct offering.In a concurrent private placement, the company will also issue short-term warrants to buy up to a total of roughly 2.1 million of its common shares, it said, adding that the warrants will have an exercise price of $3 apiece.The total gross proceeds from the offering, which is expected to take place around Wednesday, are roughly $3.2 million, Phio Pharmaceuticals said. The biotechnology company intends to use the net proceeds for working capital and other general corporate purposes.Shares of Phio Pharmaceuticals fell nearly 47% in recent trading.Price: 3.52, Change: -3.08, Percent Change: -46.71","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PHIO","BK4139"],"gpt_icon":1},{"id":"2503574594","title":"Phio Pharmaceuticals Corp trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2503574594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503574594?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:40","pubTimestamp":1736865647,"startTime":"0","endTime":"0","summary":"09:38 EST Phio Pharmaceuticals (PHIO) Corp trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-corp-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-corp-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2503579273","title":"Phio Pharmaceuticals Corp trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2503579273","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503579273?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:35","pubTimestamp":1736865314,"startTime":"0","endTime":"0","summary":"09:33 EST Phio Pharmaceuticals (PHIO) Corp trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-corp-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-corp-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2503352192","title":"Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2503352192","media":"Newsfile","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503352192?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856000,"startTime":"0","endTime":"0","summary":"Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp. , a clinical-stage biotechnology company that develops therapeutics using its INTASYL siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,063,670 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue short-term unregistered warrants to purchase up to an aggregate of 2,127,340 shares of common stock. The short-term warrants will have an exercise price of $3.00 per share, will be exercisable upon issuance and expire twenty-four months following the date of issuance. The closing of the offering is expected to occur on or about January 15, 2025, subject to the satisfaction of customary closing conditions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-3-19-120000047.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-3-19-120000047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","PHIO","BK4139","IE00BGHQF748.EUR","BK4588","NDAQ","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585",".IXIC","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2503534736","title":"Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2503534736","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503534736?lang=en_us&edition=fundamental","pubTime":"2025-01-14 03:12","pubTimestamp":1736795579,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/01/42957822/gold-down-over-1-salarius-pharmaceuticals-shares-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","BK4532","MRNA","USJW.SI","BK4139","QID","QLD","BK4094","BK4007","BK4551","LU0109394709.USD","PSQ","BK4534","TQQQ","BK4585","USAW.SI","NQmain","LU0053671581.USD","TSYW.SI","SLRX","BK4548","SQQQ","ITCI",".IXIC","MNQmain","CMTL","BK4020","LU0889565916.HKD","NVIW.SI","BK4568","LU0012050646.USD","PHIO","LU0320765992.SGD","ANF","BK4501","BK4533","BK4588"],"gpt_icon":1},{"id":"2503953611","title":"Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2503953611","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503953611?lang=en_us&edition=fundamental","pubTime":"2025-01-14 01:45","pubTimestamp":1736790344,"startTime":"0","endTime":"0","summary":"On Monday, Phio Pharmaceuticals Corp.  stock skyrocketed with a strong session volume of 201.04 million, compared to the average volume of 362.72k, according to data from Benzinga Pro.Phio reported pathologic responses for patients enrolled in the 2nd cohort, which includes two patients with a complete response or 100% tumor clearance.Phio’s ongoing Phase 1b clinical study is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in Stages 1, 2 and 4 cutaneous squamous cell carcinoma, Stage 4 melanoma, and Stage 4 Merkel cell carcinoma.Of the patients enrolled to date, six patients were diagnosed with cutaneous squamous cell carcinoma, and one patient was diagnosed with metastatic melanoma.At Day 36 , while patients in the first cohort had stable disease, results are now available for the four patients who completed treatment in the 2ndcohort:. Complete response  is reported for 2 patients with cutaneous squamous cell carcinoma.Partial response  is r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cancer-focused-phio-pharmaceuticals-stock-174544137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4526","BK4509","BK4108","IE00BYTNYN87.SGD","LU2039709279.SGD","BK4563","01698","TME","LU0359202008.SGD","BK4552","SG9999011746.SGD","BK4535","PHIO","LU0359201612.USD","LU1023057109.AUD","BK4531","BK4139","BK4571","IE00B12V2V27.USD","IE00BYQNZ168.SGD","BK4565","BK4548"],"gpt_icon":1},{"id":"2503692586","title":"Phio Pharma Shares Triple After Positive Trial Data for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2503692586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503692586?lang=en_us&edition=fundamental","pubTime":"2025-01-13 23:08","pubTimestamp":1736780880,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals shares more than tripled after the company said it saw positive results from its Phase 1b trial for its cancer treatment PH-762.Shares were recently up more than 270% to $6.30 in mid-morning trading after earlier hitting a session high of $6.49.The biotechnology company said it had positive pathologic responses for patients enrolled in the second cohort of the trial, which includes two patients with a complete response or 100% tumor clearance.Phio's ongoing Phase 1b clinical study is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoralPH-762 in cutaneous squamous cell carcinoma, melanoma and Merkel cell carcinoma.Of the patients enrolled to date, six patients were diagnosed with cutaneous squamous cell carcinoma and one patient was diagnosed with metastatic melanoma.There have been no dose-limiting toxicities, or clinically relevant treatment-emergent adverse events in the patients receiving intratumoral PH-762, said the company. The ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2503332304","title":"Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762","url":"https://stock-news.laohu8.com/highlight/detail?id=2503332304","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503332304?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:45","pubTimestamp":1736772300,"startTime":"0","endTime":"0","summary":"Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma. Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp.  is a clinical-stage biotechnology company developing therapeutics that use its INTASYL siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio today announced pathologic responses for patients enrolled in the 2nd cohort, which includes 2 patients with a complete response or 100% tumor clearance.Phio's ongoing Phase 1b clinical study  is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in Stages 1, 2 and 4 cutaneous squamous cell carcinoma, Stage 4 melanoma and Stage 4 Merkel cell carcinoma.Of the patients enrolled to date, 6 patients were diagnosed with cutaneous squamous cell carcinoma and 1 patient was diagnosed with metastatic melanoma. At Day 36 , while patients in the first cohort had stable disease, results are now available for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-promising-results-124500940.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-promising-results-124500940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0208291251.USD","LU0070302665.USD","LU0417517546.SGD","LU0256863902.USD","BK4139","LU0256863811.USD","BK4580","LU0211331839.USD","BK4585","LU1989772923.USD","PHIO","BK4161","BK4588","PH","LU0320765489.SGD","LU1989772840.SGD"],"gpt_icon":0},{"id":"2500925418","title":"Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology","url":"https://stock-news.laohu8.com/highlight/detail?id=2500925418","media":"Newsfile","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500925418?lang=en_us&edition=fundamental","pubTime":"2025-01-02 20:45","pubTimestamp":1735821900,"startTime":"0","endTime":"0","summary":"INTASYL Compound RXI-231: a promising approach to treatment of hyperpigmentation. Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp.  is a clinical-stage biotechnology company developing therapeutics that use its INTASYL siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio announced today the publication of research entitled, Self-delivering RNAi Compounds for Reduction of Hyperpigmentation, in the December, 2024 issue of Clinical, Cosmetic and Investigational Dermatology.The article presents proof-of-concept data for RXI-231, an INTASYL compound designed to target and reduce tyrosinase  gene expression. RXI-231 significantly reduced tyrosinase mRNA expression, and correspondingly reduced in melanin content in both normal human melanocytes and the 3D human epidermal culture, Melano Derm model. Application of INTASYL RXI-231 every other day visibly reduced pigmentation in the 3D epidermal cultures. RXI-231 was also ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-publication-clinical-124500858.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-publication-clinical-124500858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2493799487","title":"Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2493799487","media":"Newsfile","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493799487?lang=en_us&edition=fundamental","pubTime":"2024-12-24 02:15","pubTimestamp":1734977700,"startTime":"0","endTime":"0","summary":"Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp. , a clinical-stage biotechnology company that develops therapeutics using its INTASYL siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 240,000 shares of its common stock at a purchase price of $2.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 240,000 shares of common stock. The warrants will have an exercise price of $2.00 per share, will be exercisable upon issuance and expire five years following the date of issuance. The closing of the offering is expected to occur on or about December 24, 2024, subject to the satisfaction of customary closing conditions.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/iTBvvjzDstIeaLdzwun2ww--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/dfa377384b9cd2cda1853c12a03f06f8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/iTBvvjzDstIeaLdzwun2ww--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/dfa377384b9cd2cda1853c12a03f06f8"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-registered-direct-181500177.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-registered-direct-181500177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210150020.SGD","LU2210149790.SGD","LU2095319765.USD","PHIO","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","BK4585","BK4588","BK4112","BK4139",".IXIC","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2493875240","title":"Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2493875240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493875240?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:08","pubTimestamp":1734959307,"startTime":"0","endTime":"0","summary":"US stock futures are mixed in Monday's premarket session as investors hope to reverse last week losses during the holiday-shortened week.The Dow Jones Industrial Average futures were down 0.2%, S&P 50","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ISBC","BK4077","BK4007","IE00B19Z4B17.USD","BK4123","BK4211","BK4505","BK4539","IE00B66KJ199.SGD","PBM","IE0031619046.USD","DSGN","BK4516","TRAW","PHIO","BK4139","IE00B7SZL793.SGD","MG","RUM"],"gpt_icon":1},{"id":"2493754800","title":"Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2493754800","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493754800?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:42","pubTimestamp":1734957721,"startTime":"0","endTime":"0","summary":"Shares of Rumble Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42644814/why-rumble-shares-are-trading-higher-by-around-43-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","USJW.SI","PSQ","NVIW.SI","SQQQ","BK4023","BK4173","ATXS","HSDT","JDZG","HMC","QLD","EDBL","BK4139","KOD","BK4505","BK4077","ABAT","BK4121",".IXIC","MNQmain","RUM","BK4082","USAW.SI","BK4096","BK4583","BK4179","TPIC","TQQQ","RELI","TSYW.SI","AILE","BK4585","APTO","BNRG","CNTM","CLB","ONFO","BK4141","BK4007","PHIO","CDT","QID","BK4555","BK4133","NSANY","SIGA","BK4099"],"gpt_icon":1},{"id":"2492488046","title":"Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2492488046","media":"Newsfile","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492488046?lang=en_us&edition=fundamental","pubTime":"2024-12-20 03:28","pubTimestamp":1734636480,"startTime":"0","endTime":"0","summary":"Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp. , a clinical-stage biotechnology company that develops therapeutics using its INTASYL siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 437,192 shares of its common stock at a purchase price of $2.635 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 437,192 shares of common stock. The warrants will have an exercise price of $2.51 per share, will be exercisable upon issuance and expire five years following the date of issuance. The closing of the offering is expected to occur on or about December 20, 2024, subject to the satisfaction of customary closing conditions.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/K2O7lMKJCOJcHkZkyFQkIQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/5f0056ad4b1510da45ed38b8ef3e71f9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/K2O7lMKJCOJcHkZkyFQkIQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/5f0056ad4b1510da45ed38b8ef3e71f9"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-1-15-192800166.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-1-15-192800166.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ","PHIO","BK4585","LU2095319765.USD","BK4588",".IXIC","BK4139","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210150020.SGD","BK4112"],"gpt_icon":0},{"id":"2492176572","title":"BRIEF-Phio Pharmaceuticals Positive Safety Monitoring Committee Recommendation To Continue To Third Dose Cohort In Its Clinical Study Of Ph-762","url":"https://stock-news.laohu8.com/highlight/detail?id=2492176572","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492176572?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:15","pubTimestamp":1734617721,"startTime":"0","endTime":"0","summary":"BRIEF-Phio Pharmaceuticals Positive Safety Monitoring Committee Recommendation To Continue To Third Dose Cohort In Its Clinical Study Of Ph-762Dec 19  - Phio Pharmaceuticals Corp PHIO.O:PHIO PHARMACEUTICALS: POSITIVE SAFETY MONITORING COMMITTEE RECOMMENDATION TO CONTINUE TO THIRD DOSE COHORT IN ITS CLINICAL STUDY OF PH-762INTRATUMORAL INJECTIONS HAVE BEEN WELL TOLERATEDNO DOSE-LIMITING TOXICITIES, OR SERIOUS ADVERSE EVENTS IN PARTICIPANTS RECEIVING INTRATUMORAL PH-762Source text: [ID:n0001683168-24-008833]Further company coverage: PHIO.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NK0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":1},{"id":"2492787581","title":"Phio Pharmaceuticals: Positive Safety Monitoring Committee Recommendation to Continue to Third Dose Cohort in Its Clinical Study of Ph-762","url":"https://stock-news.laohu8.com/highlight/detail?id=2492787581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492787581?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:40","pubTimestamp":1734615658,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NK0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2492178724","title":"Phio Pharmaceuticals Corp: Intratumoral Injections Have Been Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2492178724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492178724?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:40","pubTimestamp":1734615658,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NK0HN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2492178721","title":"Phio Pharmaceuticals Corp: No Dose-Limiting Toxicities, or Serious Adverse Events in Participants Receiving Intratumoral Ph-762","url":"https://stock-news.laohu8.com/highlight/detail?id=2492178721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492178721?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:40","pubTimestamp":1734615658,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NK0HN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2492178924","title":"Phio Pharmaceuticals Safety Panel Approves Dose Escalation in Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492178924","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492178924?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:36","pubTimestamp":1734615406,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals  said Thursday its safety monitoring committee has approved progressing to a higher dose level in its phase 1b trial of PH-762, an investigational therapy for advanced skin cancers, following positive safety data from the second dose group.The company said the trial evaluates the safety and tolerability of PH-762, delivered through intratumoral injections, in stages 1, 2, and 4 cutaneous squamous cell carcinoma, stage 4 melanoma and stage 4 Merkel cell carcinoma.In the second dose group, which comprises four patients with cutaneous squamous cell carcinoma, two patients showed tumor reductions, with one achieving complete clearance, Phio said. Data from the remaining two patients is pending, the company added.The company's shares were up more than 27% in recent Thursday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2492128122","title":"Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762","url":"https://stock-news.laohu8.com/highlight/detail?id=2492128122","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492128122?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:45","pubTimestamp":1734612300,"startTime":"0","endTime":"0","summary":"Phio's Lead Compound PH-762 demonstrates encouraging safety profile in 2nd cohort with recommendation to escalate to next dose concentration. Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp.  is a clinical-stage biotechnology company that develops therapeutics using its INTASYL siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells. Phio announced today that the Safety Monitoring Committee  recommended dose escalation in its Phase 1b clinical trial designed to evaluate the safety and tolerability of PH-762 in the treatment of Stages 1, 2, and 4 cutaneous squamous cell carcinoma, Stage 4 melanoma and Stage 4 Merkel cell carcinoma.In this Phase 1b clinical study with PH-762, dosed intratumorally, the second cohort had enrolled 4 patients who were diagnosed with cutaneous squamous cell carcinoma. At Day 36 , the first two patients who completed treatment showed a complete response , respectively. Pathology data assessing efficacy da","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7V7FGeHipCk9RxUh2aTF5g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/b074266c0b37a86739038196a3b51c25","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7V7FGeHipCk9RxUh2aTF5g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/b074266c0b37a86739038196a3b51c25"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-positive-safety-124500539.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-positive-safety-124500539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PHIO","BK4585","LU1989772840.SGD","PH","BK4580","LU0208291251.USD","LU0211331839.USD","LU0256863902.USD","LU0417517546.SGD","BK4144","BK4588","BK4161","SMC","LU1989772923.USD","LU0070302665.USD","BK4139","LU0256863811.USD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2490338754","title":"Phio Pharmaceuticals Announces Publication in Frontiers in Immunology","url":"https://stock-news.laohu8.com/highlight/detail?id=2490338754","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490338754?lang=en_us&edition=fundamental","pubTime":"2024-12-12 22:21","pubTimestamp":1734013260,"startTime":"0","endTime":"0","summary":"Journal is the official publication of the International Union of Immunological Societies. Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp.  is a clinical-stage biotechnology company developing therapeutics that use its INTASYL siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells announced today its manuscript, Self-delivering RNAi Immunotherapeutic PH-762 Silences PD-1 to Generate Local and Abscopal Anti-tumor Efficacy, has been published in the December, 2024 issue of Frontiers in Immunology.The article presents preclinical proof-of-concept data for PH-762, an INTASYL compound designed to silence PD-1, is currently in clinical development for advanced cutaneous malignancies. Phio recently presented data from its second cohort in its on-going Phase 1b clinical trial showing one patient with cutaneous squamous cell carcinoma in the 2nd cohort achieved a complete response  while a second patient with squamous cell carci","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tVIsUOCkRYgX4B4s4fxB0Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/1f80e37b774204750330231ea6fb141c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tVIsUOCkRYgX4B4s4fxB0Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/1f80e37b774204750330231ea6fb141c"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-publication-frontiers-142100382.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-publication-frontiers-142100382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PHIO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"PHIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"PHIO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-1.54},{"market":"US","date":"2024-08-14","symbol":"PHIO","fiscalQuarterEnding":"2024/06","expectedEps":-4.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-3.62},{"market":"US","date":"2024-07-05","symbol":"PHIO","defaultRemindTime":1720186200000,"type":"split","dateTimestamp":1720152000000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2024-05-09","symbol":"PHIO","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1740024000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHIO","date":"2025-04-28","current":-1.363277,"percent":0.294548,"low":-5.606854,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"high":-0.115258,"avg":-1.119173,"sd":1.023678,"marketCap":9747434},"quantilePoints":[{"date":"2020-05-01","current":-0.956498,"twenty":-1.657712,"median":-1.170071,"eighty":-0.753809,"marketCap":8520484},{"date":"2020-05-08","current":-1.352468,"twenty":-1.657712,"median":-1.175971,"eighty":-0.753809,"marketCap":12047782},{"date":"2020-05-15","current":-1.142726,"twenty":-1.657712,"median":-1.178465,"eighty":-0.753809,"marketCap":10444519},{"date":"2020-05-22","current":-1.157762,"twenty":-1.657712,"median":-1.179633,"eighty":-0.753809,"marketCap":10581947},{"date":"2020-05-29","current":-1.528647,"twenty":-1.657712,"median":-1.180341,"eighty":-0.754259,"marketCap":13971835},{"date":"2020-06-05","current":-1.283061,"twenty":-1.65348,"median":-1.180341,"eighty":-0.754259,"marketCap":11727180},{"date":"2020-06-12","current":-1.242966,"twenty":-1.643898,"median":-1.180341,"eighty":-0.754259,"marketCap":11360705},{"date":"2020-06-19","current":-1.17781,"twenty":-1.638027,"median":-1.179806,"eighty":-0.754259,"marketCap":10765184},{"date":"2020-06-26","current":-1.167786,"twenty":-1.629606,"median":-1.179633,"eighty":-0.754259,"marketCap":10673566},{"date":"2020-07-02","current":-1.102631,"twenty":-1.623004,"median":-1.177076,"eighty":-0.754259,"marketCap":10078045},{"date":"2020-07-10","current":-1.448218,"twenty":-1.615926,"median":-1.170071,"eighty":-0.754259,"marketCap":13236708},{"date":"2020-07-17","current":-1.517783,"twenty":-1.603672,"median":-1.170071,"eighty":-0.754259,"marketCap":13872533},{"date":"2020-07-24","current":-1.562051,"twenty":-1.592438,"median":-1.170071,"eighty":-0.754259,"marketCap":14277148},{"date":"2020-07-31","current":-1.568375,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":14334950},{"date":"2020-08-07","current":-1.732802,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":15837809},{"date":"2020-08-14","current":-1.593726,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":13988137},{"date":"2020-08-21","current":-1.613483,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":14161544},{"date":"2020-08-28","current":-1.574051,"twenty":-1.581024,"median":-1.170071,"eighty":-0.754259,"marketCap":13815448},{"date":"2020-09-04","current":-1.343542,"twenty":-1.573962,"median":-1.170071,"eighty":-0.754259,"marketCap":11792265},{"date":"2020-09-11","current":-1.284268,"twenty":-1.568071,"median":-1.170071,"eighty":-0.754259,"marketCap":11272018},{"date":"2020-09-18","current":-1.699185,"twenty":-1.561012,"median":-1.170071,"eighty":-0.754259,"marketCap":14913747},{"date":"2020-09-25","current":-1.455503,"twenty":-1.549285,"median":-1.170071,"eighty":-0.754259,"marketCap":12774954},{"date":"2020-10-02","current":-1.455503,"twenty":-1.541964,"median":-1.170071,"eighty":-0.754259,"marketCap":12774954},{"date":"2020-10-09","current":-1.468675,"twenty":-1.529717,"median":-1.170071,"eighty":-0.754259,"marketCap":12890564},{"date":"2020-10-16","current":-1.39623,"twenty":-1.521006,"median":-1.170071,"eighty":-0.754259,"marketCap":12254707},{"date":"2020-10-23","current":-1.39623,"twenty":-1.513652,"median":-1.170071,"eighty":-0.754259,"marketCap":12254707},{"date":"2020-10-30","current":-1.369885,"twenty":-1.508404,"median":-1.170071,"eighty":-0.754259,"marketCap":12023485},{"date":"2020-11-06","current":-1.468675,"twenty":-1.505641,"median":-1.170071,"eighty":-0.754259,"marketCap":12890564},{"date":"2020-11-13","current":-1.427145,"twenty":-1.503553,"median":-1.170071,"eighty":-0.754259,"marketCap":12832892},{"date":"2020-11-20","current":-1.414288,"twenty":-1.499895,"median":-1.170071,"eighty":-0.754259,"marketCap":12717280},{"date":"2020-11-27","current":-1.478574,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":13295339},{"date":"2020-12-04","current":-1.536431,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":13815591},{"date":"2020-12-11","current":-1.819289,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":16359047},{"date":"2020-12-18","current":-1.671432,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":15029513},{"date":"2020-12-24","current":-1.735717,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":15607571},{"date":"2020-12-31","current":-1.729289,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":15549765},{"date":"2021-01-08","current":-1.954289,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":17572969},{"date":"2021-01-15","current":-1.870718,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":16821494},{"date":"2021-01-22","current":-1.857861,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":16705882},{"date":"2021-01-29","current":-3.551126,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":31931721},{"date":"2021-02-05","current":-3.755344,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":33768050},{"date":"2021-02-12","current":-3.891489,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":34992269},{"date":"2021-02-19","current":-5.385349,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":48425057},{"date":"2021-02-26","current":-3.959408,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":35602998},{"date":"2021-03-05","current":-3.502553,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31494960},{"date":"2021-03-12","current":-4.360887,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":39213092},{"date":"2021-03-19","current":-4.180913,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":37594774},{"date":"2021-03-26","current":-4.323942,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":38024743},{"date":"2021-04-01","current":-4.231616,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":37212827},{"date":"2021-04-09","current":-4.216228,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":37077508},{"date":"2021-04-16","current":-3.523782,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":30988135},{"date":"2021-04-23","current":-3.585332,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31529413},{"date":"2021-04-30","current":-3.5552,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31264430},{"date":"2021-05-07","current":-4.109257,"twenty":-1.498848,"median":-1.169531,"eighty":-0.754151,"marketCap":36136808},{"date":"2021-05-14","current":-2.624434,"twenty":-1.499955,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-05-21","current":-2.926725,"twenty":-1.501287,"median":-1.169531,"eighty":-0.754151,"marketCap":28828240},{"date":"2021-05-28","current":-3.050389,"twenty":-1.503829,"median":-1.169531,"eighty":-0.754151,"marketCap":30046334},{"date":"2021-06-04","current":-2.844282,"twenty":-1.504533,"median":-1.169531,"eighty":-0.754151,"marketCap":28016176},{"date":"2021-06-11","current":-3.036649,"twenty":-1.506728,"median":-1.169531,"eighty":-0.754151,"marketCap":29910991},{"date":"2021-06-18","current":-3.022908,"twenty":-1.511311,"median":-1.169531,"eighty":-0.754151,"marketCap":29775647},{"date":"2021-06-25","current":-3.325199,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":32753212},{"date":"2021-07-02","current":-2.967946,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":29234272},{"date":"2021-07-09","current":-2.858022,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":28151520},{"date":"2021-07-16","current":-2.50077,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24632580},{"date":"2021-07-23","current":-2.583213,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25444644},{"date":"2021-07-30","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-06","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-13","current":-2.142581,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":23279142},{"date":"2021-08-20","current":-2.10521,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":22873111},{"date":"2021-08-27","current":-2.379261,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-09-03","current":-2.528744,"twenty":-1.513652,"median":-1.169531,"eighty":-0.754151,"marketCap":27474801},{"date":"2021-09-10","current":-2.553658,"twenty":-1.517656,"median":-1.169531,"eighty":-0.754151,"marketCap":27745489},{"date":"2021-09-17","current":-2.840165,"twenty":-1.535231,"median":-1.169531,"eighty":-0.754151,"marketCap":30858397},{"date":"2021-09-24","current":-2.678226,"twenty":-1.55235,"median":-1.169531,"eighty":-0.754151,"marketCap":29098928},{"date":"2021-10-01","current":-2.478916,"twenty":-1.568375,"median":-1.169531,"eighty":-0.754151,"marketCap":26933426},{"date":"2021-10-08","current":-2.279606,"twenty":-1.575639,"median":-1.177333,"eighty":-0.754151,"marketCap":24767924},{"date":"2021-10-15","current":-2.080297,"twenty":-1.592553,"median":-1.179943,"eighty":-0.754151,"marketCap":22602423},{"date":"2021-10-22","current":-2.030469,"twenty":-1.605485,"median":-1.187834,"eighty":-0.757627,"marketCap":22061047},{"date":"2021-10-29","current":-2.092754,"twenty":-1.626655,"median":-1.191091,"eighty":-0.757651,"marketCap":22737767},{"date":"2021-11-05","current":-2.130124,"twenty":-1.639611,"median":-1.196448,"eighty":-0.757891,"marketCap":23143798},{"date":"2021-11-12","current":-1.727879,"twenty":-1.652657,"median":-1.202967,"eighty":-0.759558,"marketCap":21249455},{"date":"2021-11-19","current":-1.507767,"twenty":-1.654895,"median":-1.210405,"eighty":-0.760343,"marketCap":18542518},{"date":"2021-11-26","current":-1.529778,"twenty":-1.652657,"median":-1.212029,"eighty":-0.760343,"marketCap":18813211},{"date":"2021-12-03","current":-1.298661,"twenty":-1.652657,"median":-1.2135,"eighty":-0.760343,"marketCap":15970928},{"date":"2021-12-10","current":-1.353689,"twenty":-1.652657,"median":-1.217439,"eighty":-0.760343,"marketCap":16647662},{"date":"2021-12-17","current":-1.287655,"twenty":-1.652657,"median":-1.227086,"eighty":-0.761524,"marketCap":15835581},{"date":"2021-12-23","current":-1.298661,"twenty":-1.652657,"median":-1.228561,"eighty":-0.763642,"marketCap":15970928},{"date":"2021-12-31","current":-1.10056,"twenty":-1.652657,"median":-1.228561,"eighty":-0.77102,"marketCap":13534684},{"date":"2022-01-07","current":-1.063471,"twenty":-1.652486,"median":-1.228561,"eighty":-0.771783,"marketCap":13078565},{"date":"2022-01-14","current":-0.973005,"twenty":-1.652486,"median":-1.228561,"eighty":-0.773446,"marketCap":11966015},{"date":"2022-01-21","current":-0.946812,"twenty":-1.652486,"median":-1.228561,"eighty":-0.776821,"marketCap":11643889},{"date":"2022-01-28","current":-0.871643,"twenty":-1.652486,"median":-1.228561,"eighty":-0.781639,"marketCap":10719469},{"date":"2022-02-04","current":-0.985881,"twenty":-1.652486,"median":-1.228561,"eighty":-0.784351,"marketCap":12124370},{"date":"2022-02-11","current":-0.986432,"twenty":-1.652316,"median":-1.228561,"eighty":-0.78546,"marketCap":12131138},{"date":"2022-02-18","current":-0.917427,"twenty":-1.652316,"median":-1.228561,"eighty":-0.790609,"marketCap":11282513},{"date":"2022-02-25","current":-0.928542,"twenty":-1.652316,"median":-1.228561,"eighty":-0.794492,"marketCap":11419214},{"date":"2022-03-04","current":-0.891013,"twenty":-1.652316,"median":-1.228561,"eighty":-0.797055,"marketCap":10957680},{"date":"2022-03-11","current":-0.847211,"twenty":-1.652316,"median":-1.228561,"eighty":-0.798197,"marketCap":10419000},{"date":"2022-03-18","current":-0.934375,"twenty":-1.652316,"median":-1.228561,"eighty":-0.802126,"marketCap":11490947},{"date":"2022-03-25","current":-0.921076,"twenty":-1.652316,"median":-1.228561,"eighty":-0.806184,"marketCap":12238333},{"date":"2022-04-01","current":-0.890312,"twenty":-1.646585,"median":-1.228151,"eighty":-0.808371,"marketCap":11829577},{"date":"2022-04-08","current":-2.39386,"twenty":-1.639396,"median":-1.224535,"eighty":-0.808371,"marketCap":31807215},{"date":"2022-04-14","current":-1.21221,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":16106631},{"date":"2022-04-22","current":-1.283516,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":17054081},{"date":"2022-04-29","current":-0.855881,"twenty":-1.639396,"median":-1.214647,"eighty":-0.808371,"marketCap":11372094},{"date":"2022-05-06","current":-0.870346,"twenty":-1.639396,"median":-1.212174,"eighty":-0.808371,"marketCap":11564291},{"date":"2022-05-13","current":-0.771725,"twenty":-1.639396,"median":-1.212137,"eighty":-0.803488,"marketCap":9663542},{"date":"2022-05-20","current":-0.723513,"twenty":-1.639396,"median":-1.206863,"eighty":-0.801113,"marketCap":9059827},{"date":"2022-05-27","current":-0.796268,"twenty":-1.639396,"median":-1.201104,"eighty":-0.797537,"marketCap":9970863},{"date":"2022-06-03","current":-0.839026,"twenty":-1.639396,"median":-1.198734,"eighty":-0.797167,"marketCap":10506284},{"date":"2022-06-10","current":-0.780888,"twenty":-1.639396,"median":-1.193559,"eighty":-0.796536,"marketCap":9778275},{"date":"2022-06-17","current":-0.729621,"twenty":-1.639396,"median":-1.184786,"eighty":-0.793918,"marketCap":9136315},{"date":"2022-06-24","current":-0.740965,"twenty":-1.639504,"median":-1.17781,"eighty":-0.790818,"marketCap":9278366},{"date":"2022-07-01","current":-0.767253,"twenty":-1.639504,"median":-1.17061,"eighty":-0.788511,"marketCap":9607541},{"date":"2022-07-08","current":-0.801831,"twenty":-1.639504,"median":-1.167786,"eighty":-0.787642,"marketCap":10040522},{"date":"2022-07-15","current":-0.771399,"twenty":-1.639504,"median":-1.158325,"eighty":-0.786964,"marketCap":9659458},{"date":"2022-07-22","current":-0.784051,"twenty":-1.639504,"median":-1.151485,"eighty":-0.78508,"marketCap":9817885},{"date":"2022-07-29","current":-0.780015,"twenty":-1.639504,"median":-1.145238,"eighty":-0.783179,"marketCap":9767348},{"date":"2022-08-05","current":-0.785578,"twenty":-1.639504,"median":-1.142726,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-12","current":-0.817469,"twenty":-1.639504,"median":-1.133577,"eighty":-0.781191,"marketCap":10108816},{"date":"2022-08-19","current":-0.795488,"twenty":-1.639504,"median":-1.124069,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-26","current":-0.763346,"twenty":-1.639504,"median":-1.118863,"eighty":-0.778622,"marketCap":9439539},{"date":"2022-09-02","current":-0.760806,"twenty":-1.639504,"median":-1.112659,"eighty":-0.776493,"marketCap":9408124},{"date":"2022-09-09","current":-0.793831,"twenty":-1.639504,"median":-1.110534,"eighty":-0.775608,"marketCap":9816519},{"date":"2022-09-16","current":-0.751086,"twenty":-1.639504,"median":-1.101669,"eighty":-0.77548,"marketCap":9287927},{"date":"2022-09-23","current":-0.678959,"twenty":-1.639504,"median":-1.09706,"eighty":-0.773926,"marketCap":8396012},{"date":"2022-09-30","current":-0.631022,"twenty":-1.639504,"median":-1.091535,"eighty":-0.773184,"marketCap":7803224},{"date":"2022-10-07","current":-0.613019,"twenty":-1.639504,"median":-1.084943,"eighty":-0.772177,"marketCap":7580587},{"date":"2022-10-14","current":-0.61578,"twenty":-1.639504,"median":-1.078622,"eighty":-0.771783,"marketCap":7614734},{"date":"2022-10-21","current":-0.641847,"twenty":-1.639504,"median":-1.066994,"eighty":-0.771127,"marketCap":7937079},{"date":"2022-10-28","current":-0.646376,"twenty":-1.639504,"median":-1.055575,"eighty":-0.767034,"marketCap":7993080},{"date":"2022-11-04","current":-0.619646,"twenty":-1.639504,"median":-1.037137,"eighty":-0.763737,"marketCap":7662539},{"date":"2022-11-11","current":-0.53798,"twenty":-1.639504,"median":-1.032527,"eighty":-0.7629,"marketCap":6563358},{"date":"2022-11-18","current":-0.44813,"twenty":-1.639504,"median":-1.023521,"eighty":-0.761465,"marketCap":5467186},{"date":"2022-11-25","current":-0.45362,"twenty":-1.639504,"median":-1.020329,"eighty":-0.759288,"marketCap":5534159},{"date":"2022-12-02","current":-0.445105,"twenty":-1.631759,"median":-1.011325,"eighty":-0.755853,"marketCap":5430283},{"date":"2022-12-09","current":-0.439027,"twenty":-1.631759,"median":-0.999192,"eighty":-0.753074,"marketCap":5356134},{"date":"2022-12-16","current":-0.426844,"twenty":-1.631759,"median":-0.992495,"eighty":-0.75098,"marketCap":5207495},{"date":"2022-12-23","current":-0.401525,"twenty":-1.631759,"median":-0.985881,"eighty":-0.747725,"marketCap":4898599},{"date":"2022-12-30","current":-0.416761,"twenty":-1.631759,"median":-0.979938,"eighty":-0.745379,"marketCap":5084483},{"date":"2023-01-06","current":-0.683398,"twenty":-1.631759,"median":-0.977213,"eighty":-0.742198,"marketCap":8337460},{"date":"2023-01-13","current":-0.60363,"twenty":-1.631759,"median":-0.977213,"eighty":-0.740355,"marketCap":7364287},{"date":"2023-01-20","current":-0.592652,"twenty":-1.631759,"median":-0.977213,"eighty":-0.737547,"marketCap":7230355},{"date":"2023-01-27","current":-0.581635,"twenty":-1.631759,"median":-0.977213,"eighty":-0.734106,"marketCap":7095951},{"date":"2023-02-03","current":-0.616179,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":7517380},{"date":"2023-02-10","current":-0.515331,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6287035},{"date":"2023-02-17","current":-0.489209,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5968344},{"date":"2023-02-24","current":-0.480806,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5865834},{"date":"2023-03-03","current":-0.560162,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6833982},{"date":"2023-03-10","current":-0.516031,"twenty":-1.631759,"median":-0.977213,"eighty":-0.728426,"marketCap":6295578},{"date":"2023-03-17","current":-0.535889,"twenty":-1.631759,"median":-0.977068,"eighty":-0.726171,"marketCap":6537842},{"date":"2023-03-24","current":-0.572334,"twenty":-1.631759,"median":-0.977068,"eighty":-0.71795,"marketCap":6570398},{"date":"2023-03-31","current":-0.563264,"twenty":-1.629249,"median":-0.975604,"eighty":-0.717167,"marketCap":6466270},{"date":"2023-04-06","current":-0.5793,"twenty":-1.629249,"median":-0.975604,"eighty":-0.714469,"marketCap":6650363},{"date":"2023-04-14","current":-0.505134,"twenty":-1.631759,"median":-0.973005,"eighty":-0.711472,"marketCap":5798933},{"date":"2023-04-21","current":-0.539966,"twenty":-1.631759,"median":-0.973005,"eighty":-0.704091,"marketCap":6198807},{"date":"2023-04-28","current":-0.423323,"twenty":-1.631759,"median":-0.973005,"eighty":-0.701367,"marketCap":4859744},{"date":"2023-05-05","current":-0.509822,"twenty":-1.631759,"median":-0.973005,"eighty":-0.697146,"marketCap":5852757},{"date":"2023-05-12","current":-0.510477,"twenty":-1.631759,"median":-0.9686,"eighty":-0.690766,"marketCap":5860280},{"date":"2023-05-19","current":-0.610776,"twenty":-1.631759,"median":-0.967994,"eighty":-0.681773,"marketCap":7598053},{"date":"2023-05-26","current":-0.454756,"twenty":-1.631759,"median":-0.965521,"eighty":-0.67868,"marketCap":5657164},{"date":"2023-06-02","current":-0.408797,"twenty":-1.631759,"median":-0.96266,"eighty":-0.676522,"marketCap":5085429},{"date":"2023-06-09","current":-0.431758,"twenty":-1.631759,"median":-0.958147,"eighty":-0.664276,"marketCap":5371071},{"date":"2023-06-16","current":-0.456909,"twenty":-1.631759,"median":-0.954712,"eighty":-0.657282,"marketCap":5683949},{"date":"2023-06-23","current":-0.419183,"twenty":-1.634269,"median":-0.944146,"eighty":-0.654729,"marketCap":5214633},{"date":"2023-06-30","current":-0.392634,"twenty":-1.636779,"median":-0.938527,"eighty":-0.648646,"marketCap":4884372},{"date":"2023-07-07","current":-0.419183,"twenty":-1.636779,"median":-0.938527,"eighty":-0.644655,"marketCap":5214633},{"date":"2023-07-14","current":-0.38984,"twenty":-1.636779,"median":-0.937013,"eighty":-0.639638,"marketCap":4849608},{"date":"2023-07-21","current":-0.370977,"twenty":-1.636779,"median":-0.937013,"eighty":-0.633655,"marketCap":4614950},{"date":"2023-07-28","current":-0.375867,"twenty":-1.636779,"median":-0.937013,"eighty":-0.631022,"marketCap":4675787},{"date":"2023-08-04","current":-0.353511,"twenty":-1.639289,"median":-0.93777,"eighty":-0.629587,"marketCap":4397673},{"date":"2023-08-11","current":-0.318579,"twenty":-1.639289,"median":-0.93777,"eighty":-0.624064,"marketCap":3963121},{"date":"2023-08-18","current":-0.406633,"twenty":-1.639289,"median":-0.93777,"eighty":-0.621893,"marketCap":5065831},{"date":"2023-08-25","current":-0.413767,"twenty":-1.639289,"median":-0.93777,"eighty":-0.619457,"marketCap":5154705},{"date":"2023-09-01","current":-0.379881,"twenty":-1.639289,"median":-0.93777,"eighty":-0.610776,"marketCap":4732553},{"date":"2023-09-08","current":-0.401282,"twenty":-1.639396,"median":-0.938527,"eighty":-0.608865,"marketCap":4999176},{"date":"2023-09-15","current":-0.311217,"twenty":-1.639504,"median":-0.939799,"eighty":-0.604931,"marketCap":3877138},{"date":"2023-09-22","current":-0.249687,"twenty":-1.639504,"median":-0.939799,"eighty":-0.602435,"marketCap":3110598},{"date":"2023-09-29","current":-0.262171,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3266128},{"date":"2023-10-06","current":-0.260388,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3243909},{"date":"2023-10-13","current":-0.313892,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3910466},{"date":"2023-10-20","current":-0.244336,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3043942},{"date":"2023-10-27","current":-0.226502,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2821757},{"date":"2023-11-03","current":-0.222578,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2772876},{"date":"2023-11-10","current":-0.181915,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2266293},{"date":"2023-11-17","current":-0.205332,"twenty":-1.639826,"median":-0.942079,"eighty":-0.597918,"marketCap":2394578},{"date":"2023-11-24","current":-0.196951,"twenty":-1.639826,"median":-0.942079,"eighty":-0.591142,"marketCap":2296840},{"date":"2023-12-01","current":-0.229112,"twenty":-1.639826,"median":-0.942079,"eighty":-0.581635,"marketCap":2671909},{"date":"2023-12-08","current":-0.19276,"twenty":-1.639719,"median":-0.941575,"eighty":-0.578835,"marketCap":2247971},{"date":"2023-12-15","current":-0.155046,"twenty":-1.639719,"median":-0.941575,"eighty":-0.573898,"marketCap":1808150},{"date":"2023-12-22","current":-0.16106,"twenty":-1.639719,"median":-0.941575,"eighty":-0.569388,"marketCap":1878277},{"date":"2023-12-29","current":-0.160075,"twenty":-1.639826,"median":-0.942079,"eighty":-0.563264,"marketCap":1866793},{"date":"2024-01-05","current":-0.159656,"twenty":-1.640714,"median":-0.944146,"eighty":-0.559038,"marketCap":1861906},{"date":"2024-01-12","current":-0.146644,"twenty":-1.640714,"median":-0.944146,"eighty":-0.544651,"marketCap":1710168},{"date":"2024-01-19","current":-0.138285,"twenty":-1.641601,"median":-0.946213,"eighty":-0.539172,"marketCap":1612675},{"date":"2024-01-26","current":-0.125713,"twenty":-1.640714,"median":-0.944146,"eighty":-0.534718,"marketCap":1466068},{"date":"2024-02-02","current":-0.127599,"twenty":-1.640714,"median":-0.944146,"eighty":-0.52585,"marketCap":1488059},{"date":"2024-02-09","current":-0.127348,"twenty":-1.640714,"median":-0.944146,"eighty":-0.522459,"marketCap":1485127},{"date":"2024-02-16","current":-0.136189,"twenty":-1.640714,"median":-0.944146,"eighty":-0.51385,"marketCap":1588240},{"date":"2024-02-23","current":-0.178077,"twenty":-1.640714,"median":-0.944146,"eighty":-0.512362,"marketCap":2076736},{"date":"2024-03-01","current":-0.226284,"twenty":-1.639826,"median":-0.942079,"eighty":-0.508511,"marketCap":2638922},{"date":"2024-03-08","current":-0.184798,"twenty":-1.639826,"median":-0.942079,"eighty":-0.503269,"marketCap":2155120},{"date":"2024-03-15","current":-0.197244,"twenty":-1.639826,"median":-0.935928,"eighty":-0.492183,"marketCap":2300261},{"date":"2024-03-22","current":-0.175999,"twenty":-1.639826,"median":-0.928542,"eighty":-0.488621,"marketCap":2052495},{"date":"2024-03-28","current":-0.152134,"twenty":-1.639826,"median":-0.921076,"eighty":-0.486408,"marketCap":1774186},{"date":"2024-04-05","current":-0.156456,"twenty":-1.640714,"median":-0.916562,"eighty":-0.480806,"marketCap":1693797},{"date":"2024-04-12","current":-0.296683,"twenty":-1.640714,"median":-0.91096,"eighty":-0.469768,"marketCap":3211894},{"date":"2024-04-19","current":-0.270514,"twenty":-1.640714,"median":-0.906077,"eighty":-0.458759,"marketCap":2928586},{"date":"2024-04-26","current":-0.29944,"twenty":-1.639826,"median":-0.902569,"eighty":-0.45362,"marketCap":3241740},{"date":"2024-05-03","current":-0.329002,"twenty":-1.639826,"median":-0.896424,"eighty":-0.44813,"marketCap":3561781},{"date":"2024-05-10","current":-0.326585,"twenty":-1.639826,"median":-0.890312,"eighty":-0.445105,"marketCap":3535609},{"date":"2024-05-17","current":-0.358601,"twenty":-1.639826,"median":-0.880558,"eighty":-0.440142,"marketCap":3362961},{"date":"2024-05-24","current":-0.375934,"twenty":-1.639826,"median":-0.869368,"eighty":-0.436591,"marketCap":3525507},{"date":"2024-05-31","current":-0.368247,"twenty":-1.639826,"median":-0.863934,"eighty":-0.431758,"marketCap":3453417},{"date":"2024-06-07","current":-0.367218,"twenty":-1.639826,"median":-0.848175,"eighty":-0.425948,"marketCap":3443775},{"date":"2024-06-14","current":-0.357426,"twenty":-1.640714,"median":-0.843753,"eighty":-0.421762,"marketCap":3351941},{"date":"2024-06-21","current":-0.349053,"twenty":-1.641601,"median":-0.832901,"eighty":-0.419183,"marketCap":3273422},{"date":"2024-06-28","current":-0.337449,"twenty":-1.644264,"median":-0.825843,"eighty":-0.417785,"marketCap":3164595},{"date":"2024-07-05","current":-0.284373,"twenty":-1.644264,"median":-0.821822,"eighty":-0.414991,"marketCap":2666854},{"date":"2024-07-12","current":-0.317983,"twenty":-1.644264,"median":-0.816685,"eighty":-0.411983,"marketCap":2982048},{"date":"2024-07-15","current":-0.274733,"twenty":-1.644264,"median":-0.812746,"eighty":-0.410799,"marketCap":2576449},{"date":"2024-08-02","current":-0.161304,"twenty":-1.655347,"median":-0.803629,"eighty":-0.407754,"marketCap":1512707},{"date":"2024-08-09","current":-0.143079,"twenty":-1.655347,"median":-0.80079,"eighty":-0.40521,"marketCap":1341794},{"date":"2024-08-16","current":-0.151733,"twenty":-1.655347,"median":-0.798197,"eighty":-0.402675,"marketCap":1316285},{"date":"2024-08-23","current":-0.303609,"twenty":-1.655347,"median":-0.796603,"eighty":-0.395988,"marketCap":2633806},{"date":"2024-08-30","current":-0.261937,"twenty":-1.655347,"median":-0.793831,"eighty":-0.391029,"marketCap":2272303},{"date":"2024-09-06","current":-0.260945,"twenty":-1.655347,"median":-0.789855,"eighty":-0.385648,"marketCap":2263696},{"date":"2024-09-13","current":-0.287734,"twenty":-1.655347,"median":-0.786887,"eighty":-0.381456,"marketCap":2496090},{"date":"2024-09-20","current":-0.352226,"twenty":-1.655347,"median":-0.781191,"eighty":-0.37873,"marketCap":3055559},{"date":"2024-09-27","current":-0.35421,"twenty":-1.655347,"median":-0.779362,"eighty":-0.374682,"marketCap":3072773},{"date":"2024-10-04","current":-0.313531,"twenty":-1.655347,"median":-0.775543,"eighty":-0.372417,"marketCap":2719878},{"date":"2024-10-11","current":-0.253007,"twenty":-1.655347,"median":-0.773907,"eighty":-0.36763,"marketCap":2194838},{"date":"2024-10-18","current":-0.262929,"twenty":-1.655347,"median":-0.773508,"eighty":-0.363792,"marketCap":2280910},{"date":"2024-10-25","current":-0.293687,"twenty":-1.655347,"median":-0.773177,"eighty":-0.357426,"marketCap":2547734},{"date":"2024-10-31","current":-0.312538,"twenty":-1.655347,"median":-0.772052,"eighty":-0.353511,"marketCap":2711271},{"date":"2024-11-08","current":-0.32246,"twenty":-1.65613,"median":-0.770744,"eighty":-0.35155,"marketCap":2797343},{"date":"2024-11-15","current":-0.221257,"twenty":-1.65613,"median":-0.76436,"eighty":-0.347708,"marketCap":1919407},{"date":"2024-11-22","current":-0.29352,"twenty":-1.65613,"median":-0.76436,"eighty":-0.344977,"marketCap":2177624},{"date":"2024-11-29","current":-0.386871,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2870195},{"date":"2024-12-06","current":-0.385449,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2859643},{"date":"2024-12-13","current":-0.408362,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":3029639},{"date":"2024-12-20","current":-0.247484,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339311,"marketCap":1836081},{"date":"2024-12-27","current":-0.297265,"twenty":-1.65613,"median":-0.76436,"eighty":-0.337364,"marketCap":2205407},{"date":"2025-01-03","current":-0.270241,"twenty":-1.65613,"median":-0.763489,"eighty":-0.332534,"marketCap":2004916},{"date":"2025-01-10","current":-0.240372,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326962,"marketCap":1783320},{"date":"2025-01-17","current":-0.831105,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6165966},{"date":"2025-01-24","current":-0.881902,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6542829},{"date":"2025-01-31","current":-0.836676,"twenty":-1.656913,"median":-0.7613,"eighty":-0.326585,"marketCap":6207299},{"date":"2025-02-07","current":-0.931978,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326585,"marketCap":6914344},{"date":"2025-02-14","current":-0.821793,"twenty":-1.656913,"median":-0.763435,"eighty":-0.326962,"marketCap":6096884},{"date":"2025-02-21","current":-0.789656,"twenty":-1.656913,"median":-0.765835,"eighty":-0.326962,"marketCap":5858459},{"date":"2025-02-28","current":-0.920729,"twenty":-1.656913,"median":-0.768837,"eighty":-0.326962,"marketCap":6830892},{"date":"2025-03-07","current":-0.862782,"twenty":-1.657245,"median":-0.771897,"eighty":-0.326887,"marketCap":6400976},{"date":"2025-03-14","current":-0.856343,"twenty":-1.657245,"median":-0.773343,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-21","current":-0.856343,"twenty":-1.657245,"median":-0.775465,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-28","current":-0.843465,"twenty":-1.657245,"median":-0.777869,"eighty":-0.326887,"marketCap":6257670},{"date":"2025-04-04","current":-0.781666,"twenty":-1.657245,"median":-0.779906,"eighty":-0.326887,"marketCap":5588912},{"date":"2025-04-11","current":-1.102651,"twenty":-1.656913,"median":-0.776375,"eighty":-0.326962,"marketCap":7883954},{"date":"2025-04-17","current":-1.804338,"twenty":-1.658575,"median":-0.776375,"eighty":-0.326962,"marketCap":12901015},{"date":"2025-04-25","current":-1.490249,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":10655283},{"date":"2025-04-28","current":-1.363277,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":9747434}],"updateTime":1745984177463}}}